Leurent Guillaume, Garlantézec Ronan, Auffret Vincent, Hacot Jean Philippe, Coudert Isabelle, Filippi Emmanuelle, Rialan Antoine, Moquet Benoît, Rouault Gilles, Gilard Martine, Castellant Philippe, Druelles Philippe, Boulanger Bertrand, Treuil Josiane, Avez Bertrand, Bedossa Marc, Boulmier Dominique, Le Guellec Marielle, Le Breton Hervé
Service de Cardiologie et Maladies Vasculaires, CHU de Rennes, 2, rue Henri-le-Guilloux, 35000 Rennes, France; INSERM, U1099, Rennes, France; Université de Rennes 1, LTSI, Rennes, France.
École des Hautes Études en Santé Publique, Rennes, France.
Arch Cardiovasc Dis. 2014 May;107(5):291-8. doi: 10.1016/j.acvd.2014.04.005. Epub 2014 Jun 6.
Gender differences in presentation, management and outcome in patients with ST-segment elevation myocardial infarction (STEMI) have been reported.
To determine whether female gender is associated with higher inhospital mortality.
Data from ORBI, a regional STEMI registry of 5 years' standing, were analysed. The main data on presentation, management, inhospital outcome and prescription at discharge were compared between genders. Various adjusted hazard ratios were then calculated for inhospital mortality (women versus men).
The analysis included 5000 patients (mean age 62.6±13 years), with 1174 women (23.5%). Women were on average 8 years older than men, with more frequent co-morbidities. Median ischaemia time was 215 minutes (26 minutes longer in women; P<0.05). Reperfusion strategies in women less frequently involved fibrinolysis, coronary angiography, radial access and thrombo-aspiration. Female gender, especially in patients aged<60 years, was associated with poorer inhospital prognosis (including higher inhospital mortality: 9% vs. 4% in men; P<0.0001), and underutilization of recommended treatments at discharge. Moreover, excess female inhospital mortality was independent of presentation, revascularization time and reperfusion strategy (hazard ratio for women 1.33, 95% confidence interval 1.01-1.76; P=0.04).
One in four patients admitted for STEMI was female, with significant differences in presentation. Female gender was associated with less-optimal treatment, both in the acute-phase and at discharge. Efforts should be made to reduce these differences, especially as female gender was independently associated with an elevated risk of inhospital mortality.
已有报道称,ST段抬高型心肌梗死(STEMI)患者在临床表现、治疗及预后方面存在性别差异。
确定女性患者住院死亡率是否更高。
分析了来自一个已有5年历史的地区性STEMI注册数据库ORBI的数据。比较了不同性别的患者在临床表现、治疗、住院结局及出院处方方面的主要数据。随后计算了住院死亡率(女性与男性相比)的各种校正风险比。
分析纳入了5000例患者(平均年龄62.6±13岁),其中女性1174例(23.5%)。女性平均比男性大8岁,合并症更常见。中位缺血时间为215分钟(女性比男性长26分钟;P<0.05)。女性较少采用纤溶、冠状动脉造影、桡动脉穿刺及血栓抽吸等再灌注策略。女性,尤其是年龄<60岁的患者,住院预后较差(包括住院死亡率更高:女性为9%,男性为4%;P<0.0001),且出院时推荐治疗的使用率较低。此外,女性住院死亡率过高与临床表现、血运重建时间及再灌注策略无关(女性的风险比为1.33,95%置信区间为1.01-1.76;P=0.04)。
因STEMI入院的患者中四分之一为女性,临床表现存在显著差异。女性在急性期及出院时的治疗均欠佳。应努力减少这些差异,尤其是鉴于女性独立地与住院死亡率升高风险相关。